Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ad-RTS-hIL-12 Monotherapy or Combination with Palifosfamide in Breast Cancer
NCT01703754Phase 2Terminated
- Sponsor
- Alaunos Therapeutics
- Start
- Apr 2013
- Primary completion
- Aug 2014
- Modality
- Gene Editing, Gene Silencing, Adenoviral Vectors
- Countries
- 1
01
Overview
A Phase 2 trial of ad-rts-hil-12 in breast cancer, sponsored by Alaunos Therapeutics. Started Apr 2013; status: terminated.
02
Drugs
ad-rts-hil-12
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01703754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01703754.